Bruce Burnett

2.4k total citations
60 papers, 1.5k citations indexed

About

Bruce Burnett is a scholar working on Pharmacology, Molecular Biology and Genetics. According to data from OpenAlex, Bruce Burnett has authored 60 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Molecular Biology and 14 papers in Genetics. Recurrent topics in Bruce Burnett's work include Inflammatory mediators and NSAID effects (13 papers), Natural product bioactivities and synthesis (7 papers) and Phytoestrogen effects and research (6 papers). Bruce Burnett is often cited by papers focused on Inflammatory mediators and NSAID effects (13 papers), Natural product bioactivities and synthesis (7 papers) and Phytoestrogen effects and research (6 papers). Bruce Burnett collaborates with scholars based in United States, Italy and Netherlands. Bruce Burnett's co-authors include Robert M. Levy, Philip B. Gorelick, Yvonne Harris, Christopher K. Taylor, Jay Elliott, Francesco Squadrito, Domenica Altavilla, Lakshmi Pillai, Francesca Polito and Alessandra Bitto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

Bruce Burnett

55 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Burnett United States 22 421 266 260 215 177 60 1.5k
Mark A. Moyad United States 25 276 0.7× 161 0.6× 128 0.5× 117 0.5× 180 1.0× 119 1.6k
Mihnea‐Alexandru Găman Romania 27 375 0.9× 218 0.8× 104 0.4× 135 0.6× 278 1.6× 154 2.1k
E. Zang United States 21 494 1.2× 284 1.1× 235 0.9× 227 1.1× 205 1.2× 38 2.0k
Young Ae Cho South Korea 23 415 1.0× 103 0.4× 59 0.2× 169 0.8× 223 1.3× 46 1.5k
Marco Villa Italy 25 313 0.7× 107 0.4× 212 0.8× 313 1.5× 276 1.6× 56 2.6k
Xia Wang China 23 411 1.0× 116 0.4× 84 0.3× 93 0.4× 327 1.8× 75 1.7k
Chiho Goto Japan 21 379 0.9× 176 0.7× 93 0.4× 99 0.5× 488 2.8× 60 1.6k
Iraj Khodadadi Iran 26 523 1.2× 154 0.6× 123 0.5× 91 0.4× 165 0.9× 130 2.0k
Hong Ye China 23 483 1.1× 196 0.7× 131 0.5× 74 0.3× 248 1.4× 108 2.0k
Barbara C. Pence United States 24 551 1.3× 297 1.1× 144 0.6× 153 0.7× 151 0.9× 53 2.0k

Countries citing papers authored by Bruce Burnett

Since Specialization
Citations

This map shows the geographic impact of Bruce Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Burnett more than expected).

Fields of papers citing papers by Bruce Burnett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Burnett. The network helps show where Bruce Burnett may publish in the future.

Co-authorship network of co-authors of Bruce Burnett

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Burnett. A scholar is included among the top collaborators of Bruce Burnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Burnett. Bruce Burnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Panas, Raymond M., et al.. (2025). Treatment of Viral-induced Acute Respiratory Distress Syndrome (ARDS) With Vilobelimab: A Focus on C5a Inhibition. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3110–A3110. 1 indexed citations
2.
Chemaly, Roy F., Alexander P. J. Vlaar, Endry H. T. Lim, et al.. (2025). 85. Improved Survival with Dual Immunomodulator Treatment of ARDS by blocking C5a and IL-6 Activity: Subanalysis from the PANAMO Study in Critically Ill COVID-19 Patients. Open Forum Infectious Diseases. 12(Supplement_1).
3.
4.
Lim, Endry H. T., Bruce Burnett, Robert Zerbib, et al.. (2024). VILOBELIMAB IN COMBINATION WITH TOCILIZUMAB MAY SYNERGISTICALLY IMPROVE MORTALITY IN CRITICALLY ILL COVID-19 PATIENTS: A POST-HOC ANALYSIS OF THE PHASE III PANAMO STUDY. CHEST Journal. 166(4). A2225–A2226. 1 indexed citations
5.
Burnett, Bruce & Robert M. Levy. (2017). Proposed Industry Best Practices in Development and Marketing of Medical Foods for the Management of Chronic Conditions and Diseases while Awaiting Regulation.. PubMed. 72(1). 53–77. 2 indexed citations
6.
Burnett, Bruce & Gerard E. Mullin. (2017). Therapeutic food claims. Current Opinion in Clinical Nutrition & Metabolic Care. 20(6). 522–528. 2 indexed citations
7.
Branda, Megan E., Peter A. Noseworthy, Mark Linzer, et al.. (2017). Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial. Trials. 18(1). 443–443. 14 indexed citations
8.
9.
Jones, Theresa A., et al.. (2014). Warfarin dosing after bariatric surgery: a retrospective study of 10 patients previously stable on chronic warfarin therapy. Clinical Obesity. 4(2). 108–115. 15 indexed citations
10.
Petschow, Bryon W., Bruce Burnett, Audrey L. Shaw, Eric Weaver, & Gerald L. Klein. (2014). Serum-derived bovine immunoglobulin/ protein isolate: postulated mechanism of action for management of enteropathy. Clinical and Experimental Gastroenterology. 7. 181–181. 31 indexed citations
11.
Mitchell, Patricia L., et al.. (2014). Case Series of 10 Drug-Refractory IBS Patients Who Respond to Oral Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI). Open Journal of Gastroenterology. 4(10). 321–328. 4 indexed citations
12.
Petschow, Bryon W., Bruce Burnett, Audrey L. Shaw, Eric Weaver, & Gerald L. Klein. (2014). Dietary Requirement for Serum-Derived Bovine Immunoglobulins in the Clinical Management of Patients with Enteropathy. Digestive Diseases and Sciences. 60(1). 13–23. 21 indexed citations
13.
Burnett, Bruce & Robert M. Levy. (2012). 5-Lipoxygenase Metabolic Contributions to NSAID-Induced Organ Toxicity. Advances in Therapy. 29(2). 79–98. 47 indexed citations
14.
15.
Levy, Robert M., А. Л. Хохлов, B. Ya. Bart, et al.. (2010). Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Advances in Therapy. 27(10). 731–742. 46 indexed citations
16.
Levy, Robert M., А. Л. Хохлов, B. Ya. Bart, et al.. (2010). Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee— a subset analysis. Advances in Therapy. 27(12). 953–962. 26 indexed citations
17.
Pillai, Lakshmi, Robert M. Levy, Mesfin Yimam, et al.. (2010). Flavocoxid, an anti-inflammatory agent of botanical origin, does not affect coagulation or interact with anticoagulation therapies. Advances in Therapy. 27(6). 400–411. 12 indexed citations
18.
Burnett, Bruce, et al.. (2009). A Flavonoid Mixture, Dual Inhibitor of Cyclooxygenase and 5-Lipoxygenase Enzymes, Shows Superiority to Glucosamine/ Chondroitin for Pain Management in Moderate Osteoarthritic Dogs. 7. 1–12. 6 indexed citations
19.
Marini, Herbert, Alessandra Bitto, Domenica Altavilla, et al.. (2009). Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. Nutrition Metabolism and Cardiovascular Diseases. 20(5). 332–340. 58 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Moyad Breakdown of academic impact, for papers by Mihnea‐Alexandru Găman Breakdown of academic impact, for papers by E. Zang Breakdown of academic impact, for papers by Young Ae Cho Breakdown of academic impact, for papers by Marco Villa Breakdown of academic impact, for papers by Xia Wang Breakdown of academic impact, for papers by Chiho Goto Breakdown of academic impact, for papers by Iraj Khodadadi Breakdown of academic impact, for papers by Hong Ye Breakdown of academic impact, for papers by Barbara C. Pence
Rankless by CCL
2026